This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Inhibition of T cell - antigen presenting cell interaction

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There are experimental approaches to inhibiting the presentation of the pathogenic antigen to T helper cells:

  • copolymer and mixtures of peptides which mimic myelin protein sequences may compete with the pathogenic antigen for access to MHC II sites:
    • glatitramer acetate may work in this way

  • patients may be vaccinated against specific sequences in the T cell receptor which are found on self-reactive T cells

  • the following factors may downregulate MHC II expression:
    • TGF-beta
    • IL-10
    • interferon beta

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.